Author:
Schmoller Kurt M.,Lanz Michael C.,Kim Jacob,Koivomagi Mardo,Qu Yimiao,Tang Chao,Kukhtevich Igor V.,Schneider Robert,Rudolf Fabian,Moreno David F.,Aldea Martí,Lucena Rafael,Kellogg Doug,Skotheim Jan M.
Abstract
In their manuscript, Litsios et al.1 report a new model for how cell growth and biosynthetic activity control the G1/S transition in budding yeast. In essence, Litsios et al. claim that Start is driven by an increasing concentration of the G1 cyclin Cln3 due to a dramatic acceleration of protein synthesis in pre-Start G1 and not by the dilution of the cell cycle inhibitor Whi5. While we previously reported that Start was in part driven by cell growth during G1 diluting out the Start inhibitor Whi52, Litsios et al. report that Whi5 remains at constant concentration during G1, and changes in Whi5 concentration therefore do not contribute to Start.Since Litsios et al. directly contradict several key points of our own model of how cell growth triggers Start, we decided to investigate their claims and data. More specifically, we decided to investigate Litsios et al.’s three major claims:
Whi5 concentration remains constant during G1Cln3 concentration strongly increases prior to StartGlobal protein synthesis rates increase by 2-3 fold prior to StartWe investigated each of these three claims and found that the evidence presented by Litsios et al. does not support their claims due to inadequate analysis methods and flaws in their experiments.
Publisher
Cold Spring Harbor Laboratory